| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/29/2009 | US7638528 Drug delivery agent containing an anticarcinogenic agent such as mitoxanthrone, doxorubicin, methotrexate etc. covalently linked to a compound via an ester, amido or carabamte linkage to the S, O or amino group of the compound |
| 12/29/2009 | US7638527 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction |
| 12/29/2009 | US7638526 Inflammatory pain, chronic pain, and neuropathic pain; for inhibiting absorption of cholesterol |
| 12/29/2009 | US7638525 Trisubstituted thiophenes as progesterone receptor modulators |
| 12/29/2009 | US7638524 For reducing serum cholesterol in a mammal |
| 12/29/2009 | US7638523 e.g. tert-butyl 2-(4-(2-(4-(2-(diethylamino)ethoxy)phenylamino)pyrimidin-5-yl)-2-fluorobenzamido)acetate; C-kit kinase receptor or stem cell factor inhibitors; asthma allergic sinusitis and rhinitis, atopic and allergic dermatitis, allergic contact rheumatoid arthritis, multiple sclerosis, lupus etc. |
| 12/29/2009 | US7638522 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile |
| 12/29/2009 | US7638521 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 12/29/2009 | US7638520 Pyrimidine compounds |
| 12/29/2009 | US7638519 Compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 12/29/2009 | US7638518 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents |
| 12/29/2009 | US7638517 3-Amino-1-arylpropyl azaindoles and uses thereof |
| 12/29/2009 | US7638516 Agent for therapeutic treatment of optic nerve diseases and the like |
| 12/29/2009 | US7638515 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines |
| 12/29/2009 | US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors |
| 12/29/2009 | US7638512 Phenylaminopropanol derivatives and methods of their use |
| 12/29/2009 | US7638511 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS) |
| 12/29/2009 | US7638510 Racemic mixtures; treating drug abuse, drug dependence |
| 12/29/2009 | US7638509 Diene compounds and formulations |
| 12/29/2009 | US7638508 Glucocorticosteroid compound having anti-inflammatory activity |
| 12/29/2009 | US7638507 Compositions for treatment of inflammatory diseases |
| 12/29/2009 | US7638506 cationic surfactants; wear resistance; kneading, extrusion; sustained release |
| 12/29/2009 | US7638504 Hepatitis a viricide |
| 12/29/2009 | US7638503 Small molecule stimulators of neuronal growth |
| 12/29/2009 | US7638502 Treatment of EBV and KHSV infection and associated abnormal cellular proliferation |
| 12/29/2009 | US7638501 Administering of pyrimidine-based nucleoside such as triacetyluridine; dihydroorotate dehydrogenase and uridine monophosphate synthetase inhibitors |
| 12/29/2009 | US7638500 Brevenal derivatives; used to treat diseases characterized by decreased mucus clearance or mucociliary dysfunction such as cystic fibrosis; COPD and asthma; and to treat brevetoxin and ciguatoxin poisoning |
| 12/29/2009 | US7638497 For enhancing apoptosis and treating proliferative disorders; antitumor agents |
| 12/29/2009 | US7638496 Nucleoside analogs with carboxamidine modified monocyclic base |
| 12/29/2009 | US7638488 Such as acarbose or castanospermine; interferons |
| 12/29/2009 | US7638482 Protein kinase C zeta as a drug target for arthritis and other inflammatory diseases |
| 12/29/2009 | US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 12/29/2009 | US7638335 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
| 12/29/2009 | US7638334 Method for generating engineered cells by homologously recombining segments having increased degeneracy |
| 12/29/2009 | US7638324 Useful in modulating apoptosis; diagnosis of prostate/ovarian cancer, and leukemia |
| 12/29/2009 | US7638283 Amyloid β protein (globular assembly and uses thereof) |
| 12/29/2009 | US7638272 administering a polypeptide to the cancer cells of the mammal in vivo for sensitizing the cancer cells to the therapeutic chemotherapy, radiation treatment; gene expressed polypeptide; secreted protein acidic and rich in cystein |
| 12/29/2009 | US7638145 Cutting tree; aeration; purification |
| 12/29/2009 | US7638143 Fluidized bed granulation, compression to form tablets |
| 12/29/2009 | US7638134 Insertion sites in fowlpox vectors |
| 12/29/2009 | US7638073 Photochromic material comprising a proteorhodopsin apoprotein and a retinal analog |
| 12/29/2009 | US7637870 Tissue penetrating catheters having integral imaging transducers and their methods of use |
| 12/29/2009 | CA2563761C Inhibitors of the hiv integrase enzyme |
| 12/29/2009 | CA2524043C 1-(2h-pyrazol-3-yl)-3-{4-'1-(benzoyl)-piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations |
| 12/29/2009 | CA2484164C Androgen pharmaceutical composition and method for treating depression |
| 12/29/2009 | CA2480125C Use of carbon-2-modified-19-nor-vitamin d analogs to induce the formation of new bone |
| 12/29/2009 | CA2478799C Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 12/29/2009 | CA2477851C Small molecule entry inhibitors |
| 12/29/2009 | CA2468703C Controlled release polymeric compositions of bone growth promoting compounds |
| 12/29/2009 | CA2466490C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 12/29/2009 | CA2465877C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 12/29/2009 | CA2465349C Transdermal drug for the treatment of neural paralysis and dysfunction |
| 12/29/2009 | CA2464768C Method and composition for potentiating an opiate analgesic |
| 12/29/2009 | CA2451932C Pyrrolopyrimidines as protein kinase inhibitors |
| 12/29/2009 | CA2447521C Delivery of antihistamines through an inhalation route |
| 12/29/2009 | CA2443019C Kappa-opiate agonists for the treatment of bladder diseases |
| 12/29/2009 | CA2429720C Tricyclic compounds useful for the inhibition of farnesyl protein transferase |
| 12/29/2009 | CA2429440C Dehalogeno-compounds |
| 12/29/2009 | CA2428511C Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors |
| 12/29/2009 | CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors |
| 12/29/2009 | CA2425215C Compositions and methods for enhancing paracellular permeability across epithelial and endothelial barriers |
| 12/29/2009 | CA2424797C Methods of inducing cancer cell death and tumor regression |
| 12/29/2009 | CA2424522C Substituted benzene derivatives or salts thereof |
| 12/29/2009 | CA2423296C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| 12/29/2009 | CA2422871C Stable solid dosage forms of amino acids and processes for producing same |
| 12/29/2009 | CA2419258C Intermediates in cephalosporin production |
| 12/29/2009 | CA2418829C Process for the preparation of baccatin iii derivatives |
| 12/29/2009 | CA2415683C Indoloquinazolinones |
| 12/29/2009 | CA2412575C Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone |
| 12/29/2009 | CA2411760C 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 12/29/2009 | CA2411058C Skin treatment using a new retinoid |
| 12/29/2009 | CA2410311C Barbituric acid analogs as therapeutic agents |
| 12/29/2009 | CA2387013C 6-position substituted indolinones, the preparation thereof and their use as pharmaceutical compositions |
| 12/29/2009 | CA2384624C Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 12/29/2009 | CA2370250C Di-aryl acid derivatives as ppar receptor ligands |
| 12/29/2009 | CA2351488C Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them |
| 12/29/2009 | CA2348993C Substituted phenethylsulfones and method of reducing tnf.alpha. levels |
| 12/29/2009 | CA2348695C Method of preparing delta-9-tetrahydrocannabinol esters |
| 12/29/2009 | CA2345369C Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use |
| 12/29/2009 | CA2339054C E-isomeric fullerene derivatives |
| 12/29/2009 | CA2304948C Pharmaceutical composition for the treatment of inflammatory bowel disease |
| 12/29/2009 | CA2300243C Process for preparing n-[5-(diphenylphosphinoylmethyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl]-n-methylmethanesulphonamide |
| 12/29/2009 | CA2299548C Composition and method for regulating cell proliferation and cell death |
| 12/29/2009 | CA2287214C Substituted benzopyran derivatives for the treatment of inflammation |
| 12/29/2009 | CA2282720C Dolastatin-15 derivatives in combination with taxanes |
| 12/29/2009 | CA2264802C Antioxidant derived from lentil and its preparation and uses |
| 12/24/2009 | US20090320148 Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using the same |
| 12/24/2009 | US20090318882 Intraosseous dental anesthesia |
| 12/24/2009 | US20090318711 Non-Covalent Inhibitors of AmpC ß-Lactamase |
| 12/24/2009 | US20090318687 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds |
| 12/24/2009 | US20090318567 Lycopene for the treatment of metabolic dysfunction |
| 12/24/2009 | US20090318566 Gossypol derivatives, production method thereof and uses of same |
| 12/24/2009 | US20090318565 Novel Compositions for the Enhancement of the Anti-oxidant Potential of Hydrogenated Curcuminoids or Combinations Thereof |
| 12/24/2009 | US20090318564 Process for preparing and drying solid rasagiline base |
| 12/24/2009 | US20090318562 Use of Bupropion Metabolites for the Treatment of Inflammatory Disorders |
| 12/24/2009 | US20090318561 Colchicine products, method of manufacture, and methods of use |
| 12/24/2009 | US20090318560 Formulations for cathepsin k inhibitors |
| 12/24/2009 | US20090318559 Modafinil-based treatment for premature ejaculation |
| 12/24/2009 | US20090318558 Solvent system of hardly soluble drug with improved dissolution rate |
| 12/24/2009 | US20090318557 Dermatological compositions |